Phacilitate Leaders World

Features, Workshops & Networking Agenda


The power of perseverance - how Dendreon bounced back

23 Jan 2019
Phacilitate: Talks
  • Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy.
  • Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. 
  • While the journey, which began in 1992, has been filled with many ups and downs, three ingredients to this company’s success has remained constant, it’s employees’: 
    1) resilience in the face of adversity,
    2) attitude to make the fight against cancer personal, and
    ) perseverance to master the skills our patients count on each and every day.  
Dwayne Soisson, Senior Director - Operations - Dendreon
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman